The therapeutic potential of interleukin 10 in infection and inflammation
- PMID: 11197608
The therapeutic potential of interleukin 10 in infection and inflammation
Abstract
Interleukin 10 (IL-10), a cytokine with inhibitory activity on inflammation and cell-mediated immune responses, holds enormous potential for the treatment of inflammatory and autoimmune disorders. In addition, IL-10 has also been implicated in the immunopathogenesis of a number of infectious diseases through the use of IL-10 knock-out or IL-10 transgenic mouse models. In this review, we delineate infectious and inflammatory conditions in which IL-10 has shown potential for therapeutic manipulation. Specifically, we review the role of IL-10 in human endotoxemia/sepsis and in HIV infection, conditions for which preliminary phase I trials have recently been undertaken. It is suggested that the therapeutic potential of IL-10 to selectively ameliorate human infectious and inflammatory processes can be realized through a careful selection of the clinical conditions in which patients are undergoing concomitant treatment with anti-microbial regimens.
Similar articles
-
Phosphodiesterase inhibition decreases nuclear factor-kappaB activation and shifts the cytokine response toward anti-inflammatory activity in acute endotoxemia.J Trauma. 2005 Sep;59(3):575-82. J Trauma. 2005. PMID: 16361898
-
Biodegradable microspheres targeting mucosal immune-regulating cells: new approach for treatment of inflammatory bowel disease.J Gastroenterol. 2003 Mar;38 Suppl 15:59-62. J Gastroenterol. 2003. PMID: 12698874 Review.
-
Chlamydia pneumoniae infection in IL-10 knock out mice: accelerated clearance but severe pulmonary inflammatory response.Microb Pathog. 2008 Jul;45(1):25-9. doi: 10.1016/j.micpath.2008.02.004. Epub 2008 Apr 1. Microb Pathog. 2008. PMID: 18456450
-
The importance of systemic cytokines in the pathogenesis of polymicrobial sepsis and dehydroepiandrosterone treatment in a rodent model.Shock. 2003 Oct;20(4):338-46. doi: 10.1097/01.shk.0000081408.57952.22. Shock. 2003. PMID: 14501948
-
Interleukin-12, interleukin-23, and psoriasis: current prospects.J Am Acad Dermatol. 2007 Dec;57(6):1059-68. doi: 10.1016/j.jaad.2007.07.016. Epub 2007 Aug 15. J Am Acad Dermatol. 2007. PMID: 17706835 Review.
Cited by
-
The role of Interleukin-10 and 13 in tuberculosis-associated pulmonary dysfunction.Caspian J Intern Med. 2019 Spring;10(2):223-227. doi: 10.22088/cjim.10.2.223. Caspian J Intern Med. 2019. PMID: 31363402 Free PMC article.
-
Immunomodulatory activity of Nerium indicum through inhibition of nitric oxide and cyclooxygenase activity and modulation of TH1/TH2 cytokine balance in murine splenic lymphocytes.Cytotechnology. 2016 Aug;68(4):749-61. doi: 10.1007/s10616-014-9826-9. Epub 2015 Feb 14. Cytotechnology. 2016. PMID: 25680696 Free PMC article.
-
Immature anti-inflammatory response in neonates.Clin Exp Immunol. 2004 Jan;135(1):130-6. doi: 10.1111/j.1365-2249.2004.02313.x. Clin Exp Immunol. 2004. PMID: 14678274 Free PMC article.
-
IL-10 Has Differential Effects on the Innate and Adaptive Immune Systems of Septic Patients.J Immunol. 2019 Oct 15;203(8):2088-2099. doi: 10.4049/jimmunol.1900637. Epub 2019 Sep 9. J Immunol. 2019. PMID: 31501258 Free PMC article.